HHS and CMS announced Tuesday they deferred over $1 billion in federal Medicaid payments to two states, including $867.5 million to California, citing high-risk claims including home-based services. The deferrals represent a federal payment hold while CMS reviews claims for potential fraud, waste, or abuse. The action takes effect immediately. This is significant because payment deferrals can strain state budgets and delay provider payments, potentially disrupting network adequacy and access to home and community-based services that many MCOs coordinate or manage under managed long-term services and supports contracts.
Why it mattersPayment deferrals to states can cascade to MCOs through delayed capitation payments or disrupted provider networks, particularly for MLTSS plans managing home-based services.
Finance · LTSS · Managed Care
The Department of Health and Human Services published a correction to the 2027 Notice of Benefit and Payment Parameters final rule, originally issued May 20, 2026. The correction addresses typographical errors in the rule governing qualified health plan standards, risk adjustment, and the Basic Health Program. These are technical corrections only and do not change the substantive policy or operational requirements established in the May rule. The corrections are effective immediately upon publication.
Why it mattersWhile the Payment Parameters rule primarily governs Marketplace plans, managed care organizations operating Basic Health Programs or serving dual-eligible populations through Marketplace coordination must ensure their systems reflect the corrected regulatory text.
Managed Care · Finance
Sen. Andy Kim (D-N.J.) introduced legislation to automatically enroll all American children in Medicare from birth through age 25, calling the proposal MediKids. The bill would create universal federal coverage for children regardless of family income. No timeline for committee consideration or floor action has been announced. The proposal would fundamentally restructure pediatric coverage currently delivered through Medicaid, CHIP, and commercial insurance, though passage prospects remain uncertain given divided government.
Why it mattersIf enacted, this proposal would eliminate state Medicaid and CHIP managed care contracts for children, shifting all pediatric coverage to federal Medicare and ending a major line of business for Medicaid MCOs.
CHIP · Managed Care
Four Republican members of the U.S. House of Representatives joined a Democratic discharge petition related to the Affordable Care Act on December 17, 2025. The Association for Community Affiliated Plans issued a statement from CEO Margaret A. Murray responding to this development. A discharge petition can force a floor vote on legislation if it receives 218 signatures. The bipartisan support suggests potential movement on ACA-related legislation that could affect Medicaid expansion states and marketplace programs.
Why it mattersBipartisan ACA legislation could affect Medicaid managed care organizations operating in expansion states, marketplace qualified health plans with Medicaid lines of business, and dual-eligible coordination arrangements.
Managed Care
A federal district court in Maryland issued a preliminary injunction on July 16, 2026, blocking eight provisions of CMS's 2027 notice of benefit and payment parameters final rule. The enjoined provisions include expanded out-of-pocket maximums for bronze and catastrophic plans, broader catastrophic plan eligibility, relaxed network adequacy standards, and a new pathway for non-network plans to qualify as marketplace coverage. The court found plaintiffs likely to succeed on Administrative Procedure Act claims and that irreparable harm would occur without relief. The injunction took effect July 20, 2026, while the remainder of the rule proceeded as scheduled.
Why it mattersMedicaid MCOs in states with marketplace partnerships or serving dual-eligible populations must monitor whether enjoined network adequacy relaxations affect benchmark plan standards or coordination of benefits requirements.
Managed Care
A JAMA Health Forum study published July 17, 2026 finds that some compounding pharmacies are making minor compositional changes to semaglutide and tirzepatide products to evade FDA restrictions on compounding copies of approved drugs. The FDA previously added these GLP-1 medications to its drug shortage list due to surging demand, which legally permitted compounding. As shortages resolve and FDA moves to restrict compounding of these products, some pharmacies are altering formulations to maintain legal compounding status. This affects Medicaid managed care organizations that cover GLP-1s for diabetes and obesity, as it creates uncertainty around formulary management, prior authorization protocols, and pharmacy network oversight.
Why it mattersMedicaid MCOs covering GLP-1 medications face potential increased costs and quality concerns from proliferation of modified compounded formulations that may lack the safety and efficacy data of FDA-approved products, requiring enhanced pharmacy benefit management and utilization review protocols.
Pharmacy · Managed Care
Congress has allocated $50 billion over five years for rural healthcare programs, including facilities in Eastern Oregon. The funding represents less than one-tenth of projected Medicaid funding losses anticipated over the next decade. The allocation comes amid broader concerns about federal Medicaid cuts that could disproportionately affect rural safety-net providers. The timing and distribution mechanisms for the rural health funding have not been specified.
Why it mattersMedicaid managed care organizations with rural networks face potential provider stability issues if safety-net facilities lose Medicaid revenue far exceeding the federal rural health allocation.
Managed Care · Finance